Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2009

Open Access 01-01-2009 | Research

A dosimetric comparison of different treatment plans of palliative spinal bone irradiation: analysis of dose coverage with respect to ICRU 50 report

Authors: Fundagul Andic, Sule Baz Cifci, Yasemin Ors, Umar Niang, Ahmet Dirier, Mustafa Adli

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2009

Login to get access

Abstract

Background

This study aimed to analyze three-dimensional (3D) dosimetric data of conventional two-dimensional (2D) palliative spinal bone irradiation using different reference points and treatment plans with respect to the International Commission on Radiation Units and Measurements (ICRU) Report 50.

Methods

Forty-five simulation CT scans of 39 patients previously treated for thoraco-lumbar spinal bone metastases were used. Three different treatment plans were created: (1) single posterior field plans using the ICRU reference points (ICRUrps); (2) single posterior field plans using the International Bone Metastasis Consensus Working Party reference points (IBMCrps); (3) two opposed anterior-posterior (AP-PA) field plans using the ICRUrps. The intended dose range for planning target volume (PTV) was 90% to 110% of the prescribed dose for AP-PA field plans. Cumulative dose-volume histograms were generated for each plan, and minimum, maximum and mean doses to the PTV, medulla spinalis, esophagus and intestines were analyzed.

Results

The mean percentages of minimum, maximum and mean PTV doses ± standard deviation were, respectively, 91 ± 1.3%, 108.8 ± 1.3% and 99.7 ± 1.3% in AP-PA field plans; 77.3 ± 2.6%, 122.2 ± 4.3% and 99.8 ± 2.6% in ICRUrp single field plans; and 83.7 ± 3.3%, 133.9 ± 7.1% and 108.8 ± 3.3% in IBMCrp single field plans. Minimum doses of both single field plans were significantly lower (p < 0.001) while maximum doses were significantly higher (p < 0.001) than AP-PA field plans. Minimum, maximum and mean doses were higher in IBMCrp single field plans than in ICRUrp single field plans (p < 0.001). The mean medulla spinalis doses were lower in AP-PA field plans than single posterior field plans (p < 0.001). Maximum doses for medulla spinalis were higher than 120% of the prescribed dose in 22 of 45 (49%) IBMCrp single field plans. Mean esophagus and intestinal doses were higher (p < 0.001) in AP-PA field plans than single field plans, however, less than 95% of the prescribed dose.

Conclusion

In palliative spinal bone irradiation, 2D conventional single posterior field radiotherapy did not accomplish the ICRU Report 50 recommendations for PTV dose distribution, while the AP-PA field plans did achieve the intended dose ranges with a homogenous distribution and reasonable doses to the medulla spinalis, esophagus and intestines.
Appendix
Available only for authorised users
Literature
1.
go back to reference Agarawal JP, Swangsilpa T, Linden van der Y, Rades D, Jeremic B, Hoskin PJ: The Role of External Beam Radiotherapy in the Management of Bone Metastases. Clin Oncol (R Coll Radiol). 2006, 18 (10): 747-760. 10.1016/j.clon.2006.09.007.CrossRef Agarawal JP, Swangsilpa T, Linden van der Y, Rades D, Jeremic B, Hoskin PJ: The Role of External Beam Radiotherapy in the Management of Bone Metastases. Clin Oncol (R Coll Radiol). 2006, 18 (10): 747-760. 10.1016/j.clon.2006.09.007.CrossRef
2.
go back to reference ICRU 50: Prescribing, recording, and reporting photon beam therapy. 1993, Bethesda, MD: International Commission on Radiation Units and Measurements Press ICRU 50: Prescribing, recording, and reporting photon beam therapy. 1993, Bethesda, MD: International Commission on Radiation Units and Measurements Press
3.
go back to reference Chow E, Wu JS, Hoskin P, Coia LR, Bentzen SM, Blitzer PH: International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol. 2002, 64: 275-280. 10.1016/S0167-8140(02)00170-6.CrossRef Chow E, Wu JS, Hoskin P, Coia LR, Bentzen SM, Blitzer PH: International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol. 2002, 64: 275-280. 10.1016/S0167-8140(02)00170-6.CrossRef
4.
5.
go back to reference Rades D, Stalpers LJ, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC, Poortmans P, Schild SE: Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol. 2005, 23: 3366-3375. 10.1200/JCO.2005.04.754.CrossRef Rades D, Stalpers LJ, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC, Poortmans P, Schild SE: Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol. 2005, 23: 3366-3375. 10.1200/JCO.2005.04.754.CrossRef
6.
go back to reference Chow E, Harris K, Fan G, Tsao M, Sze WM: Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol. 2007, 25: 1423-1436. 10.1200/JCO.2006.09.5281.CrossRef Chow E, Harris K, Fan G, Tsao M, Sze WM: Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol. 2007, 25: 1423-1436. 10.1200/JCO.2006.09.5281.CrossRef
7.
go back to reference Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD: Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy – a systematic review of randomised trials. Clin Oncol (R Coll Radiol). 2003, 15 (6): 345-352. 10.1016/S0936-6555(03)00113-4.CrossRef Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD: Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy – a systematic review of randomised trials. Clin Oncol (R Coll Radiol). 2003, 15 (6): 345-352. 10.1016/S0936-6555(03)00113-4.CrossRef
8.
go back to reference Wu JS, Wong R, Johnston M, Bezjak A, Whelan T: Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003, 55: 594-605.CrossRef Wu JS, Wong R, Johnston M, Bezjak A, Whelan T: Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003, 55: 594-605.CrossRef
9.
go back to reference Maranzano E, Bellavita R, Rossi R, De Angelis V, Frattegiani A, Bagnoli R, Mignogna M, Beneventi S, Lupattelli M, Ponticelli P, Biti GP, Latini P: Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol. 2005, 23: 3358-3365. 10.1200/JCO.2005.08.193.CrossRef Maranzano E, Bellavita R, Rossi R, De Angelis V, Frattegiani A, Bagnoli R, Mignogna M, Beneventi S, Lupattelli M, Ponticelli P, Biti GP, Latini P: Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol. 2005, 23: 3358-3365. 10.1200/JCO.2005.08.193.CrossRef
10.
go back to reference Jeremic B, Shibamoto Y, Acimovic L, Milicic B, Milisavljevic S, Nikolic N, Aleksandrovic J, Igrutinovic I: A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys. 1998, 42: 161-167.CrossRef Jeremic B, Shibamoto Y, Acimovic L, Milicic B, Milisavljevic S, Nikolic N, Aleksandrovic J, Igrutinovic I: A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys. 1998, 42: 161-167.CrossRef
11.
go back to reference Hoskin PJ, Price P, Easton D, Regan J, Austin D, Palmer S, Yarnold JR: A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol. 1992, 23: 74-78. 10.1016/0167-8140(92)90338-U.CrossRef Hoskin PJ, Price P, Easton D, Regan J, Austin D, Palmer S, Yarnold JR: A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol. 1992, 23: 74-78. 10.1016/0167-8140(92)90338-U.CrossRef
12.
go back to reference Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M: Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005, 97: 798-804.CrossRef Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M: Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005, 97: 798-804.CrossRef
13.
go back to reference Steenland E, Leer JW, van Houwelingen H, Post WJ, Hout van den WB, Kievit J, de Haes H, Martijn H, Oei B, Vonk E, Steen-Banasik van der E, Wiggenraad RG, Hoogenhout J, Wárlám-Rodenhuis C, van Tienhoven G, Wanders R, Pomp J, van Reijn M, van Mierlo I, Rutten E: The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol. 1999, 52: 101-109. 10.1016/S0167-8140(99)00110-3.CrossRef Steenland E, Leer JW, van Houwelingen H, Post WJ, Hout van den WB, Kievit J, de Haes H, Martijn H, Oei B, Vonk E, Steen-Banasik van der E, Wiggenraad RG, Hoogenhout J, Wárlám-Rodenhuis C, van Tienhoven G, Wanders R, Pomp J, van Reijn M, van Mierlo I, Rutten E: The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol. 1999, 52: 101-109. 10.1016/S0167-8140(99)00110-3.CrossRef
14.
go back to reference Linden van der YM, Lok JJ, Steenland E, Martijn H, van Houwelingen H, Marijnen CA, Leer JW, Dutch Bone Metastasis Study Group: Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys. 2004, 59: 528-537.CrossRef Linden van der YM, Lok JJ, Steenland E, Martijn H, van Houwelingen H, Marijnen CA, Leer JW, Dutch Bone Metastasis Study Group: Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys. 2004, 59: 528-537.CrossRef
Metadata
Title
A dosimetric comparison of different treatment plans of palliative spinal bone irradiation: analysis of dose coverage with respect to ICRU 50 report
Authors
Fundagul Andic
Sule Baz Cifci
Yasemin Ors
Umar Niang
Ahmet Dirier
Mustafa Adli
Publication date
01-01-2009
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2009
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-28-2

Other articles of this Issue 1/2009

Journal of Experimental & Clinical Cancer Research 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine